Zacks is a joke. Why they keep advertising that they don't seem to know what they're doing is beyond me.
"Also, what type of revenue are we talking here with Mudan? Substantial?"
What I'm looking for at the next earnings call is visibility in terms of when the ramp is going to start. The ramp continues to be two years away in perpetuity. While it is good that Gopi continues to expand the echo system (who knows what kind of revenue Mudan will translate into), the investors would like to know when the share price will rise. I would also like to see Gopi address competitors entering the market. What does he think about CAVM now that they have added connectivity to their portfolio? He can't continue to be dismissive of the competition. What is the strategy?
Analyst consensus places the next quarter, which we should get guidance on at the call this quarter at around $44M. Guiding to this target would be a good sign.
If forward guidance during the upcoming (will AMCC be announcing this soon?) conference call is at the consensus $44M I think that would signal the beginning of the ramp, and would do a lot to spur investment in AMCC shares, driving the share price up. Forward guidance that does not once again disappoint could be the single greatest factor in driving the share price past $7 in my humble opinion. Announcement by CAVM of the date for the earnings call has driven their share price up. I will be checking with their conference call by comparison to see where CAVM stands relative to AMCC and where they both stand relative to their total addressable markets.
If the ramp keeps getting pushed back, then Zepf, like Billy Martin with VTSS, will have to come to a decision about how to optimize shareholder value, and this may be a sale in lieu of a long position in shares of AMCC. It could be the whole reason why they selected and keep Marty McDermott around. Gopi, like Gardner, seems not to have a lot of urgency in terms of execution. Even some of the analysts during the last conference call seemed disappointed at the tepid numbers.
Post by christopher on Jul 7, 2016 14:25:09 GMT -5
I agree with you phobos, on what will drive a $7.00+ share price and the Quarter 1 conference call had better show guidance of a "ramp" beginning. A RAMP moving UP! ( I read somewhere that Q1 CC will be held on 7/28/16 unofficial)
Hasn't Gopi's quarterly earnings always come in within range for the last couple of years?
as far as investment firms purchasing shares(quantities listed elsewhere on this site)
All but just one or two investment firms have been adding to their share base, over the last couple of months.
Wouldn't the time before a ramp up be the best time for investment firms to add to their share base?
A reason to be keeping the share price held below $7.00. All on low volume.
All of the above will help to build a "base" for AMCC share price, helping sustain a $7.00+ share price once a ramp begins.
my .02
All we need now is good guidance that is on time, followed by good revenue, followed by a good double digit + sale.
Last Edit: Jul 9, 2016 13:28:22 GMT -5 by christopher
Post by christopher on Jul 9, 2016 10:22:26 GMT -5
Excluding Zacks, we have had a very long run with AMCC in a Hold position.
The very reason why Q 1 CC had better have growth in revenue and also notification of a Ramp actually beginning.
This is what is needed for the present Hold position to be upgraded to a BUY position.
Q4 2016 conference call CEO Gopi made a few remarks regarding added revenue beginning in Q1 of 2017:
A positive outlook?
"We have added three major Tier 1 design wins with our X-Weave OTN and Secure Ethernet product families that will have revenue contribution starting this fiscal year."
"With our X-Gene product line, including PAM4, secure Ethernet and OTN products, we are poised to capture meaningful revenue growth in the high- volume rapidly growing datacenter optical connectivity market."
regarding X-Gene 3 "We are extremely excited by the accelerating customer traction that has resulted"
Last Edit: Jul 9, 2016 13:55:30 GMT -5 by christopher
Gopi has been extremely accurate with forward guidance which likely shows the good relationship that AMCC has with its customers (a good sign).
In order for the (fiscal) 2017 projections to come through, we will have unremarkable earnings (meet, or slightly exceed) this quarter, and significant upward guidance for next quarter (~$44M). I think everyone will be looking very carefully at the forward guidance for next quarter.
Gopi can get as excited as he likes, but the investors will only be excited by accelerating returns.
Post by christopher on Jul 20, 2016 15:48:36 GMT -5
7/20/16
Here we are, 1 week before Q1 earnings call and we have broken through the $7.00 share price!
Waaaaaahhhhooooooo!!! finished the day at $7.10 share.
If we have a better than average earnings call then I would have to believe that we will be pushing well over $7.00 share price. AMCC has recently had a boatload of new products released, along with the traction that X-Gene has gained. All leading to substantial revenue to be occurring over the next couple of quarters! Get your shares before it is too late!!!